SUNNYVALE, Calif.--(BUSINESS WIRE)--Covidien (NYSE: COV), a leading global provider of healthcare products, today announced the launch of the HALO60 Ablation Catheter, the latest addition to the HALO family of catheters for the endoscopic treatment of Barrett’s esophagus. The HALO product line joined the Covidien portfolio earlier when the Company acquired BÂRRX Medical, a leader in the development of minimally invasive medical devices to remove potentially precancerous tissue from the gastrointestinal tract.
